Business Wire

CORRECTING and REPLACING Green Motion Air by Eaton, the Electric Aircraft Charger That Helps Airports to Reduce Their Carbon Footprint, Will Be on Show at the 2023 Paris Air Show

16.6.2023 15:18:00 EEST | Business Wire | Press release

Share

Booth details have been added to the tenth paragraph of release issued 14 June 2023 at 8:00 a.m. CET, and the fourth paragraph, second sentence should read: Green Motion Air is already well-proven after becoming the world’s first non-OEM charger to be approved by EASA, the European Union Aviation Safety Agency.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230613296919/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Green Motion Air by Eaton (Photo: Business Wire)

The updated release reads:

GREEN MOTION AIR BY EATON, THE ELECTRIC AIRCRAFT CHARGER THAT HELPS AIRPORTS TO REDUCE THEIR CARBON FOOTPRINT, WILL BE ON SHOW AT THE 2023 PARIS AIR SHOW

Growing demand for air travel means that airport operators are looking for new ways to curb carbon emissions on the ground, making electric vehicle and aircraft charging an attractive proposition.

Eaton, the intelligent power management company, is responding with the roll-out of Green Motion Air to airport operators across Europe, starting with a demonstration of the technology at the 2023 Paris Air Show at Le Bourget Airport, 19th to 25th June.

Green Motion Air is built on Eaton's proprietary DC charging technology, bringing unrivalled conversion efficiency of 96% to charging electric planes and electric vertical take-off and landing (eVTOL) aircraft.

François Randin, business development director, Energy Transition, Digital and Services Eaton, said: “This latest version of technology that was formerly called SKYCHARGE was initially developed by Green Motion - now part of Eaton - and Pipistrel, the company that made history with its Velis Electro by obtaining the first-ever type certificate for electric propulsion in aviation. Green Motion Air is already well-proven after becoming the world’s first non-OEM charger to be approved by EASA, the European Union Aviation Safety Agency.

“We will display Green Motion Air at the Paris Air Show to show its versatility as a standalone charger either stationary or mounted on wheels for ultimate mobility on airside. We will explain to airport operators and OEMs alike the role it will play in a broader strategy of airport electrification thanks to its online and vehicle-to-grid (V2G) functionality.”

Airports can be transformed into energy hubs through Eaton’s Buildings as a Grid approach to the energy transition, which unites the power needs of buildings and electric vehicles with on-site renewable energy generation.

Explaining how this approach works at an airport, Randin said: “Buildings as a Grid is strategic so it could mean coupling on-airport renewable energy generated from assets such as solar panels, with EV charging stations in airport car parks, Green Motion Air, and other electrical equipment too.”

The Buildings as a Grid approach is based on a concept called sector coupling that links energy consumption with renewable energy generation and storage to reduce costs and carbon emissions and lessen pressure on the grid. It is a flexible and scalable approach, so airport operators can start with Green Motion Air, for instance, and plan to expand their infrastructure via Eaton’s related hardware and software at a later stage.

The product benefits of Green Motion Air include a 10" colour touch-screen display for ease of use, which enables the user to pause and resume the charging session, cybersecurity protection, and secure user authentication. It is suitable for indoor and outdoor mounting, with cable extensions available for enhanced flexibility, or mobile use.

Green Motion Air will be on show in the TotalEnergies booth, the SolarStratos booth, and details will also be available at the Eaton Chalet, at the 2023 Paris Air Show at Paris-Le Bourget Airport, 19th to 25th June.

Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.

Founded in 1911, Eaton is marking its 100th anniversary of being listed on the New York Stock Exchange. We reported revenues of $20.8 billion in 2022 and serve customers in more than 170 countries. For more information, visit www.eaton.com. Follow us on Twitter and LinkedIn.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

VeraGrishchenko@eaton.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release

Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye